Radiology, Vol 182, 359-363, Copyright © 1992 by Radiological Society of North America

ARTICLES

Lymphoma: predictive value of Ga-67 scintigraphy after treatment

D Front, S Ben-Haim, O Israel, R Epelbaum, N Haim, E Even-Sapir, GM Kolodny and E Robinson
Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel.

The negative predictive value (PV-) and positive predictive value (PV+) of gallium-67 scintigraphy and computed tomography (CT) were compared after treatment in 43 patients with Hodgkin disease and in 56 patients with non-Hodgkin lymphoma. The usefulness of these studies in predicting survival was also evaluated. In patients with Hodgkin disease, the PV- of Ga-67 scintigraphy was 0.84 and of CT was 0.88. The PV+ was 0.80 for Ga-67 studies and only 0.29 for CT. In patients with non-Hodgkin lymphoma, the PV- of Ga-67 scintigraphy was 0.84 and of CT was 0.80. The PV+ was 0.73 and 0.35, respectively. For both groups, the differences in disease-free survival between patients with negative and positive Ga-67 studies were significant (P less than .05 in Hodgkin disease and P less than .001 in non-Hodgkin lymphoma), but the differences were not significant for CT. These data show that, after treatment of patients with lymphoma, Ga-67 scintigraphy is a good predictor of clinical outcome and can be used beneficially in patient treatment.

This article has been cited by other articles:

				O. Israel, M. Mekel, R. Bar-Shalom, R. Epelbaum, N. Hermony, N. Haim, E. J. Dann, A. Frenkel, M. Ben-Arush, and D. Gaitini Bone Lymphoma: 67Ga Scintigraphy and CT for Prediction of Outcome After Treatment J. Nucl. Med., October 1, 2002; 43(10): 1295 - 1303. [Abstract] [Full Text] [PDF]

				O. Israel, M. Mor, D. Gaitini, Z. Keidar, L. Guralnik, A. Engel, A. Frenkel, R. Bar-Shalom, and A. Kuten Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG J. Nucl. Med., September 1, 2002; 43(9): 1129 - 1136. [Abstract] [Full Text] [PDF]

				V. J. Lowe and G. A. Wiseman Assessment of Lymphoma Therapy Using 18F-FDG PET J. Nucl. Med., August 1, 2002; 43(8): 1028 - 1030. [Full Text] [PDF]

				D. Gossot, P. Girard, Eric de Kerviler, P. Brice, J.-D. Rain, T. Leblanc, and D. Grunenwald Thoracoscopy or CT-Guided Biopsy for Residual Intrathoracic Masses After Treatment of Lymphoma Chest, July 1, 2001; 120(1): 289 - 294. [Abstract] [Full Text] [PDF]

				D. Front, R. Bar-Shalom, M. Mor, N. Haim, R. Epelbaum, A. Frenkel, D. Gaitini, G. M. Kolodny, and O. Israel Hodgkin Disease: Prediction of Outcome with 67Ga Scintigraphy after One Cycle of Chemotherapy Radiology, February 1, 1999; 210(2): 487 - 491. [Abstract] [Full Text]

				B. L. Maria, K. Rehder, T. A. Eskin, L. M. Hamed, E. B. Fennell, R. G. Quisling, J. P. Mickle, R. B. Marcus Jr, W. E. Drane, N. P. Mendenhall, et al. Topical Review Article: Brainstem Glioma: I. Pathology, Clinical Features, and Therapy J Child Neurol, April 1, 1993; 8(2): 112 - 128. [Abstract] [PDF]